CAPTRUST Financial Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,660
| Closed | -$27.1K | – | 2625 |
|
|
2023
Q1 | $27.1K | Buy |
+14,660
| New | +$27.1K | ﹤0.01% | 2238 |
|
|
2022
Q4 | – | Sell |
-35,599
| Closed | -$83K | – | 2247 |
|
|
2022
Q3 | $83K | Buy |
35,599
+13,099
| +58% | +$30.5K | ﹤0.01% | 1956 |
|
|
2022
Q2 | $68K | Sell |
22,500
-2,000
| -8% | -$6.04K | ﹤0.01% | 2514 |
|
|
2022
Q1 | $166K | Hold |
24,500
| – | – | ﹤0.01% | 1860 |
|
|
2021
Q4 | $205K | Hold |
24,500
| – | – | ﹤0.01% | 1624 |
|
|
2021
Q3 | $182K | Hold |
24,500
| – | – | ﹤0.01% | 1630 |
|
|
2021
Q2 | $167K | Buy |
24,500
+3,000
| +14% | +$20.4K | ﹤0.01% | 1644 |
|
|
2021
Q1 | $221K | Buy |
21,500
+10,000
| +87% | +$103K | ﹤0.01% | 1412 |
|
|
2020
Q4 | $80K | Buy |
11,500
+500
| +5% | +$3.48K | ﹤0.01% | 1610 |
|
|
2020
Q3 | $99K | Hold |
11,000
| – | – | ﹤0.01% | 1345 |
|
|
2020
Q2 | $73K | Buy |
+11,000
| New | +$73K | ﹤0.01% | 1477 |
|